A method of labelling proteins with 211At using the intermediate compound, paraastatobenzoic acid, is presented. Using antibody proteins so labelled, no loss of immunological function is seen. The advantages gained in purity of product for this particular labelling protocol is discussed in relation to other, comparable procedures.
|Original language||English (US)|
|Number of pages||2|
|Journal||The International Journal Of Applied Radiation And Isotopes|
|State||Published - 1979|
ASJC Scopus subject areas
- Nuclear Energy and Engineering
- Radiology Nuclear Medicine and imaging